去年，史赛克表现最佳的业务板块Medical实现营收4.20B美元。United States的营收贡献最高，去年达到19.01B美元。最近一个季度，截至2026-06-30，史赛克表现最佳的业务板块Medical实现营收1.12B美元。United States的营收贡献最高，达到1.57B美元。

业务

营业收入

占比

年报

年报

单季报

Medical

Trauma and Extremities

Endoscopy

Instruments

Knees

Neurovascular

Vascular

Hips

Other

Spinal Implants

Neuro Cranial

Spinal Implant

Spine

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Medical

4.20B(16.74%)

3.85B(16.53%)

3.46B(15.95%)

3.03B(15.47%)

2.61B(14.27%)

2.52B(16.39%)

2.26B(14.20%)

Trauma and Extremities

3.95B(15.72%)

3.51B(15.05%)

3.15B(14.51%)

2.81B(14.33%)

2.66B(14.58%)

1.72B(11.18%)

1.54B(9.65%)

Endoscopy

3.81B(15.16%)

3.39B(14.54%)

3.03B(13.99%)

2.42B(12.37%)

2.14B(11.72%)

1.76B(11.45%)

1.98B(12.44%)

Instruments

3.18B(12.67%)

2.83B(12.16%)

2.57B(11.85%)

2.28B(11.63%)

2.11B(11.55%)

1.86B(12.10%)

1.96B(12.29%)

Knees

2.66B(10.57%)

2.45B(10.50%)

2.27B(10.48%)

2.00B(10.19%)

1.85B(10.11%)

1.57B(10.18%)

1.81B(11.39%)

Neurovascular

2.48B(9.89%)

1.31B(5.61%)

1.23B(5.65%)

1.20B(6.12%)

1.19B(6.50%)

973.00M(6.32%)

924.00M(5.80%)

Vascular

1.97B(7.84%)

--(--)

Hips

1.86B(7.43%)

1.70B(7.31%)

1.54B(7.12%)

1.41B(7.21%)

1.34B(7.34%)

1.21B(7.83%)

1.38B(8.68%)

Other

815.00M(3.24%)

712.00M(3.06%)

509.00M(2.35%)

777.00M(3.97%)

826.00M(4.52%)

714.00M(4.64%)

701.00M(4.40%)

Spinal Implants

185.00M(0.74%)

--(--)

Neuro Cranial

--(--)

2.14B(9.17%)

1.55B(7.14%)

1.38B(7.02%)

1.21B(6.64%)

972.00M(6.31%)

1.06B(6.64%)

Spinal Implant

--(--)

707.00M(3.03%)

1.19B(5.48%)

1.15B(5.85%)

1.17B(6.39%)

1.05B(6.80%)

1.16B(7.26%)

Spine

--(--)

707.00M(3.03%)

1.19B(5.48%)

1.15B(5.85%)

1.17B(6.39%)

1.05B(6.80%)

1.16B(7.26%)

地区

营业收入

占比

年报

年报

单季报

United States

Europe & Middle East & Africa (EMEA) (Region)

Asia Pacific (Region)

Other countries

Europe

Ireland

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

19.01B(75.67%)

16.94B(74.99%)

6.19B(54.15%)

5.61B(53.85%)

5.29B(52.52%)

10.46B(72.85%)

10.96B(73.62%)

9.85B(72.41%)

9.06B(72.80%)

8.25B(72.82%)

7.12B(71.55%)

6.56B(67.78%)

5.98B(66.33%)

5.66B(65.36%)

5.27B(63.43%)

Europe & Middle East & Africa (EMEA) (Region)

3.18B(12.67%)

2.90B(12.82%)

2.62B(22.90%)

2.35B(22.52%)

2.30B(22.80%)

1.82B(12.67%)

1.89B(12.68%)

1.79B(13.18%)

1.57B(12.59%)

1.44B(12.73%)

1.27B(12.74%)

1.37B(14.17%)

1.32B(14.59%)

1.27B(14.62%)

--(--)

Asia Pacific (Region)

2.16B(8.62%)

2.02B(8.94%)

1.95B(17.02%)

1.89B(18.08%)

1.97B(19.57%)

1.63B(11.36%)

1.62B(10.86%)

1.53B(11.26%)

1.41B(11.35%)

1.31B(11.60%)

1.25B(12.58%)

1.37B(14.14%)

1.32B(14.62%)

1.34B(15.43%)

--(--)

Other countries

765.00M(3.05%)

735.00M(3.25%)

677.00M(5.92%)

578.00M(5.54%)

515.00M(5.11%)

448.00M(3.12%)

422.00M(2.84%)

428.00M(3.15%)

405.00M(3.25%)

322.00M(2.84%)

312.00M(3.14%)

378.00M(3.91%)

402.00M(4.46%)

397.00M(4.59%)

1.66B(19.93%)

Europe

--(--)

1.32B(15.88%)

Ireland

--(--)

63.00M(0.76%)